Heron Therapeutics (HRTX) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HRTX Hot Sheet
Join SI Premium – FREE
Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.70), $0.02 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Simulations Plus (SLP) Tops Q3 EPS by 7c
- Citi upgrades Knight-Swift and Saia to Buy after trucking stock pullback
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
